Coronavirus Mutations: FDA Singles Out 4 Molecular Tests That Can Give False Readings
Executive Summary
The US FDA says it’s concerned that virus mutations could lead to false results with certain COVID-19 tests and lists tests it has found are prone to lower sensitivity, based on the agency’s own analysis.
You may also be interested in...
Coronavirus Variants Spur FDA To Write New Guidance For COVID-19 Test Developers
The US agency’s immediately-in-effect guidance document – released on 22 February – explains how makers of COVID-19 diagnostics can assess whether their tests are impacted by mutations of the virus.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.